AnGes, Inc.

OTCPK:AMGX.F Stock Report

Market Cap: US$140.8m

AnGes Past Earnings Performance

Past criteria checks 0/6

AnGes's earnings have been declining at an average annual rate of -19.9%, while the Biotechs industry saw earnings growing at 22% annually. Revenues have been growing at an average rate of 32.2% per year.

Key information

-19.95%

Earnings growth rate

-7.44%

EPS growth rate

Biotechs Industry Growth17.04%
Revenue growth rate32.15%
Return on equity-1,304.64%
Net Margin-4,374.49%
Next Earnings Update09 May 2025

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How AnGes makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

OTCPK:AMGX.F Revenue, expenses and earnings (JPY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 24643-28,1285,5743,783
30 Sep 24521-9,7952,4304,261
30 Jun 24448-6,1072,7415,253
31 Mar 24249-6,3502,6405,564
31 Dec 23152-7,4372,5116,172
30 Sep 23124-9,3182,5857,311
30 Jun 2387-12,1192,3827,546
31 Mar 2368-14,6872,27710,311
31 Dec 2267-14,7142,10410,999
30 Sep 2265-11,9172,41110,820
30 Jun 2272-13,6502,10212,439
31 Mar 2268-13,2992,24810,634
31 Dec 2164-13,6752,18910,783
30 Sep 2155-12,9874,25910,406
30 Jun 2146-9,7633,4917,653
31 Mar 2145-6,6042,4395,584
31 Dec 2039-4,2091,5713,796
30 Sep 2031-4,1541,1642,508
30 Jun 20170-3,6731,1852,189
31 Mar 20255-3,4851,2682,843
31 Dec 19326-3,7501,1842,215
30 Sep 19656-3,5641,1602,879
30 Jun 19605-3,8221,0593,268
31 Mar 19612-3,6439222,539
31 Dec 18610-2,9968832,539
30 Sep 18387-2,6079021,665
30 Jun 18373-2,6129551,610
31 Mar 18356-2,7908831,725
31 Dec 17365-3,7648612,600
30 Sep 17513-4,3127973,178
30 Jun 17514-4,2507273,170
31 Mar 17514-5,0577704,072
31 Dec 16514-4,7768004,188
30 Sep 16366-4,9599444,140
30 Jun 16359-4,9289054,231
31 Mar 16432-4,4908693,763
31 Dec 15430-4,1438823,532
30 Sep 15948-3,2868083,213
30 Jun 15975-3,4418093,232
31 Mar 15908-2,8147622,738
31 Dec 14909-2,3696872,338
30 Sep 14381-2,5286732,013
30 Jun 14351-1,7256451,315
31 Mar 14448-1,4816571,156

Quality Earnings: AMGX.F is currently unprofitable.

Growing Profit Margin: AMGX.F is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: AMGX.F is unprofitable, and losses have increased over the past 5 years at a rate of 19.9% per year.

Accelerating Growth: Unable to compare AMGX.F's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: AMGX.F is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (38.5%).

Return on Equity

High ROE: AMGX.F has a negative Return on Equity (-1304.64%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/04 01:08
End of Day Share Price 2024/12/05 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

AnGes, Inc. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kiyokazu YamazakiIchiyoshi Research Institute Inc.
Toshiyuki IwataMizuho Securities Co., Ltd.
Shinichiro MuraokaMorgan Stanley